Literature DB >> 15976979

Atrial pacing failure following termination of atrial fibrillation by acute administration of disopyramide phosphate.

Ryuko Anzawa1, Shin-Ichiro Ishikawa, Yasuyuki Tanaka, Fumiko Okazaki, Seibu Mochizuki.   

Abstract

Atrial pacing failure occurred after termination of atrial fibrillation by acute administration of disopyramide phosphate in a 71-year-old woman implanted with an AAI pacemaker for sick sinus syndrome. The atrial pacing threshold showed an 810% increase; however, the serum concentration of disopyramide corresponded to therapeutic level. Infusion of the same dose of disopyramide phosphate used during the period of atrial pacing rhythm did not increase the atrial pacing threshold. In the present patient, we supposed that atrial pacing failure did not occur by the effect of disopyramide alone, but rather was a reciprocal action in response to atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976979     DOI: 10.1007/s10840-005-0647-9

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  10 in total

Review 1.  Ventricular pacing failure after a single oral dose of pilsicainide in a patient with a permanent pacemaker and paroxysmal atrial fibrillation.

Authors:  T Numata; H Abe; T Nagatomo; K Kohshi; Y Nakashima
Journal:  Pacing Clin Electrophysiol       Date:  2000-09       Impact factor: 1.976

2.  Rate-dependent failure of ventricular capture in patients treated with oral propafenone.

Authors:  J Soriano; J Almendral; A Arenal; D San Román; J L Delcan; M E Josephson
Journal:  Eur Heart J       Date:  1992-02       Impact factor: 29.983

3.  Regional myocardial blood flow in patients with sick sinus syndrome randomized to long-term single chamber atrial or dual chamber pacing--effect of pacing mode and rate.

Authors:  J C Nielsen; M Bøttcher; T T Nielsen; A K Pedersen; H R Andersen
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

4.  Acute loss of capture due to flecainide acetate.

Authors:  D Antonelli; N A Freedberg; T Rosenfeld
Journal:  Pacing Clin Electrophysiol       Date:  2001-07       Impact factor: 1.976

5.  Fatal overdosage with disopyramide.

Authors:  A M Hayler; D W Holt; G N Volans
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

6.  Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy.

Authors:  Prashanthan Sanders; Joseph B Morton; Peter M Kistler; Jitendra K Vohra; Jonathan M Kalman; Paul B Sparks
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

Review 7.  Atrial stunning: basics and clinical considerations.

Authors:  Ijaz A Khan
Journal:  Int J Cardiol       Date:  2003-12       Impact factor: 4.164

8.  Disopyramide: serum level and arrhythmia conversion.

Authors:  A P Niarchos
Journal:  Am Heart J       Date:  1976-07       Impact factor: 4.749

9.  Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing thresholds.

Authors:  K J Hellestrand; P J Burnett; J R Milne; R S Bexton; A W Nathan; A J Camm
Journal:  Pacing Clin Electrophysiol       Date:  1983-09       Impact factor: 1.976

10.  Clinical and electrophysiological characteristics of atrial standstill.

Authors:  Y Nakazato; Y Nakata; T Hisaoka; M Sumiyoshi; S Ogura; H Yamaguchi
Journal:  Pacing Clin Electrophysiol       Date:  1995-06       Impact factor: 1.976

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.